InnovaSuMMa and PRIS projects: Health Innovation through Precomercial Public Procurement (PCP)

Thursday 10th April, 2014

1. PRIS Project

• Management: Agreement with the Ministry of Economy and Competitiveness

H2050 e Innova Saúde projects

Characteristics 2x45 M€

• Objectives: • Provide the Galician public Health System with innovative

products and services • Foster innovation in companies through Innovative Public

Procurement (IPP)

• Temporal Scope: 2012-2015

• Financing: Regional Development Funds, within the Operational R&D&i Plan – Technological Fund 2007-2013 (80% ERDF)

PRIS Methodology

CPP

Pre-screening

Phase 0

32 projects

Projects with results and potential to reach the market •New therapies •Diagnostic tools •Medical software •Mediacal devices •Health services

With external experts and focused on the market

Working with innovative companies with capacities and technologies that cover Research Groups development needs. Sharing Risks and benefits

Evaluation

PHASE I

20 projects

Elaboration Business Plan

PHASE II

10 projects

Co-development PPP financed through PCP

PHASE II

4-5 projects

Fase 0

Fase I

PRIS Porfolio-Phase 1

PRIS Porfolio Phase 2 and 3

Type of services demanded PROJECTS € investment

CRO 4 projects 3, 8, 30 330.000,00

Medical device companies 2 projects 17, 27 300.000,00

Vaccine GMP manufacturer 1 project 28 150.000,00

Serious Games/Media Company 1 project 16 120.000,00 Preformulation and Drug development company 1 project 6 200.000,00

Pharmaceutical company (Nephrology) 1 project 14 85.000,00

Total projected investments (just private sector) 1.185.000,00

PRIS Budget

2. InnovaSuMMa Project

InnovaSuMMa project

8

• Continuing with previous experience in Galicia in PPI

• InnovaSumma : based on the project developed by ASEBIO and adapted SERGAS priorities

• Inspired in other European PCP projects

• Aiming the introduction of technologies based on biomarkers for new patient assistance protocols based on Personalized medicine for Oncology

9

Changing traditional procurement practices

Legal experts Procurement

Oncology Doctors Galician

Oncology Society

Industrial Association

Health Assistance Director

Technology evaluation

Project management

MINECO Health Innovation

Director

10

Project executed in 3 stages /budget

Stage 1 (opened to 8-10 companies ): 1month-long. scientific-technological proposals and the proposed work plan to the selected Galician Oncology services

Stage 2 (opened to 6 companies): Six months-long. Evaluating the most promising projects resulting from phase 1, with real patients. Proving the selected technologies in real clinical environments

Stage 3 (opened to 4 company): Six months-long. . Full deployment of the best technologies to evaluate the potential of biomarkers and change current clinical protocols in the area of oncology.

Maximum budget per company

Maximum number of companies

PHASE 1 6.000,00 € 8

PHASE 2 70.000,00 € 6

PHASE 3 40.000,00 € 4

TOTAL BUDGET 628.000,00€

InnovaSuMMa Budget

Thank you!

Sergio Figueiras innovacion@sergas.es